About the Keynote Speakers

Caitlin Hudon

Keynote @ May 4^th 11AM

Caitlin Hudon is Principal Data Scientist at OnlineMedEd, an adult learning company based in Austin, TX. She has over a decade of experience helping companies get value out of their data in a variety of industries including IoT, marketing, higher education, non-profits, and startups. She is cofounder of R-Ladies Austin and Data Mishaps Night. She's also into tacos, hiking, traveling, live music, and hanging out with her almost-2-year-old.

Nadja Oertelt

Keynote @ May 5^th 1PM

Nadja is the co-founder of Massive Science, a science media company that aims to engage the public and scientists in new ways. She is the current Chief Content Officer at Science Friday and a former senior producer at Mashable and producer at Buzzfeed and Vice. Nadja is passionate about bringing art into quantitative spaces. In 2007, Nadja graduated from MIT with a BS in Neuroscience and she has held positions in labs at MIT, Harvard, and Cambridge University.

To learn more, visit Nadja's website here http://www.nadjaoertelt.com/ or follow Nadja on twitter here https://twitter.com/nadjao

Isabelle Bedrosian, MD

Keynote @ May 6^th 3PM

Dr. Isabelle Bedrosian serves as the Principal Investigator of the Alliance A11104, Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer, which has recently closed and is awaiting data maturation. Dr. Bedrosian is also actively involved in translational research efforts investigating molecular pathways in early tumorigenesis that may serve as novel targets for prevention and using machine learning approaches for identification of imaging biomarkers predictive of future breast cancer risk. Her work has supported by several grants, including the Susan G. Komen for the Cure, Avon Foundation and American Society of Oncology Advanced Clinical Research Award in Breast Cancer and the NCI. Dr Bedrosian serves as Co- Chair of the Prevention Committee within the Alliance Cooperative Group and a member of the NCI Cancer Prevention Steering Committee. Most recently she served as member of the ASCO/SSO/ASTRO expert panel to develop guidelines for management of breast cancer in germline mutation carriers.